Cargando…
Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2
Herpes simplex virus 2 (HSV-2) 0ΔNLS is a live HSV-2 ICP0 (-) mutant vaccine strain that is profoundly attenuated in vivo due to its interferon-hypersensitivity. Recipients of the HSV-2 0ΔNLS vaccine are resistant to high-dose HSV-2 challenge as evidenced by profound reductions in challenge virus sp...
Autores principales: | Halford, William P., Geltz, Joshua, Messer, Ronald J., Hasenkrug, Kim J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682860/ https://www.ncbi.nlm.nih.gov/pubmed/26670699 http://dx.doi.org/10.1371/journal.pone.0145228 |
Ejemplares similares
-
Pan-HSV-2 IgG Antibody in Vaccinated Mice and Guinea Pigs Correlates with Protection against Herpes Simplex Virus 2
por: Halford, William P., et al.
Publicado: (2013) -
Herpes Simplex Virus 2 (HSV-2) Infected Cell Proteins Are among the Most Dominant Antigens of a Live-Attenuated HSV-2 Vaccine
por: Geltz, Joshua J., et al.
Publicado: (2015) -
The UL13 and US3 Protein Kinases of Herpes Simplex Virus 1 Cooperate to Promote the Assembly and Release of Mature, Infectious Virions
por: Gershburg, Svetlana, et al.
Publicado: (2015) -
A System for Creating Stable Cell Lines that Express a Gene of Interest from a Bidirectional and Regulatable Herpes Simplex Virus Type 1 Promoter
por: Chambers, Christopher B., et al.
Publicado: (2015) -
Vaccination Route as a Determinant of Protective Antibody Responses against Herpes Simplex Virus
por: Burn Aschner, Clare, et al.
Publicado: (2020)